Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment

• Main Authors: Vidhi M. Shah (Author), Syed Rizvi (Author), Alexander Smith (Author), Motoyuki Tsuda (Author), Madeline Krieger (Author), Carl Pelz (Author), Kevin MacPherson (Author), Jenny Eng (Author), Koei Chin (Author), Michael W. Munks (Author), Colin J. Daniel (Author), Adel Al-Fatease (Author), Galip Gürkan Yardimci (Author), Ellen M. Langer (Author), Jonathan R. Brody (Author), Brett C. Sheppard (Author), Adam WG. Alani (Author), Rosalie C. Sears (Author)
• Format: Book
• Published: MDPI AG, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pancreatic cancer remains a formidable challenge due to limited treatment options and its aggressive nature. In recent years, the naturally occurring anticancer compound juglone has emerged as a potential therapeutic candidate, showing promising results in inhibiting tumor growth and inducing cancer...